Gene · 57124
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation analysis of serum PACAP-38, fibulin-3 and TEM1 levels with cardiac function and prognosis in chronic heart failure patients. | J Med Biochem | 2026 | 42780739 | PubTator, text mining | PubMed |
| Coupling continuous directed evolution with base editors identifies combinatorial antibiotic resistance. | Biotechnol Lett | 2026 | 42763377 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in diabetic foot ulcers: pathogenesis, biomarkers, and translational potential. | Front Clin Diabetes Healthc | 2026 | 42757034 | PubTator, text mining | PubMed |
| CD248: Guardian of Synovial Fibroblast Fate. | Arthritis Rheumatol | 2026 | 42703737 | PubTator, text mining | PubMed |
| Immortalized smooth muscle cells enhance in vitro vasculogenesis. | Angiogenesis | 2026 | 42622755 | PubTator, text mining | PubMed |
| CD55 downregulation identifies a pathogenic CD4+ T cell axis linked to p38 MAPK signaling in rheumatoid arthritis. | J Immunol | 2026 | 42618653 | PubTator, text mining | PubMed |
| From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma. | Front Oncol | 2026 | 42518818 | PubTator, text mining | PubMed |
| The CAFs-derived YAP1-periostin axis forms a fibrotic tumor microenvironment to promote metastatic lung tumor growth. | J Transl Med | 2026 | 42469883 | PubTator, text mining | PubMed |
| [Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma. | Oncol Lett | 2026 | 42465859 | PubTator, text mining | PubMed |
| Long-term exposure to air pollution, proteomic aging clocks, and liver-related outcomes in Chinese adults. | Environ Res | 2026 | 42419615 | PubTator, text mining | PubMed |
| Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells. | Adv Exp Med Biol | 2026 | 42401775 | PubTator, text mining | PubMed |
| Characterizing tumor-associated endothelial cells in clear cell renal cell carcinoma via scRNA-seq and Bulk RNA-seq: construction of a prognostic risk signature. | Arch Biochem Biophys | 2026 | 42392347 | PubTator, text mining | PubMed |
| Unveiling the role of glycoproteins in hepatocellular carcinoma: from biomarkers to therapeutic interventions. | 3 Biotech | 2026 | 42383071 | PubTator, text mining | PubMed |
| Proteomics analysis of empagliflozin in patients without diabetes or overt heart failure from empagliflozin and cardiac remodeling in people without diabetes CardioLink-7 randomized clinical trial. | Cardiovasc Endocrinol Metab | 2026 | 42367684 | PubTator, text mining | PubMed |
| Molecular-Genetic Basis of Pulmonary Arterial Hypertension (PAH). | Curr Issues Mol Biol | 2026 | 42353577 | PubTator, text mining | PubMed |
| The epidemiology and clinical characteristics of carbapenem-resistant Enterobacteriaceae (CRE) isolates from children in eastern China. | Front Microbiol | 2026 | 42293536 | PubTator, text mining | PubMed |
| Immortalized smooth muscle cells enhance in vitro vasculogenesis. | Res Sq | 2026 | 42245805 | PubTator, text mining | PubMed |
| Modular Input-Output Biosensor Design Using De Novo Protein Switches. | ACS Sens | 2026 | 42233743 | PubTator, text mining | PubMed |
| Immortalized smooth muscle cells enhance in vitro vasculogenesis. | bioRxiv | 2026 | 42182209 | PubTator, text mining | PubMed |
| Soluble CD248 in the tumor microenvironment: From stromal byproduct to functional decoy. | Biomed Pharmacother | 2026 | 42140059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57124/papers